{"id":8640,"date":"2017-08-10T00:11:53","date_gmt":"2017-08-09T21:11:53","guid":{"rendered":"http:\/\/seragpsych.com\/wordpress\/?p=8640"},"modified":"2017-08-10T01:28:03","modified_gmt":"2017-08-09T22:28:03","slug":"drug-discovery","status":"publish","type":"post","link":"https:\/\/seragpsych.com\/wordpress\/drug-discovery\/","title":{"rendered":"Drug Discovery"},"content":{"rendered":"

 <\/p>\n

Magid Abou-Gharbia, Ph.D., FRSC<\/strong>\u00a0is currently the Associate Dean for Research, Laura H. Carnell Professor of Medicinal Chemistry and Director of the Moulder Center for Drug Discovery Research (MCDDR) at the School of Pharmacy, Temple University, Philadelphia, PA. He is responsible for Setting and implementing School of Pharmacy research strategies to promote the school\u2019s research and entrepreneurial enterprise. Prior to joining Temple University in 2008, Magid spent 26 years at Wyeth Pharmaceuticals where he was senior Vice President and Head of Chemical and Screening Sciences. As Senior Vice President & Head of Chemical & Screening Sciences at Wyeth, he was responsible for overseeing and directing Wyeth chemistry and screening research efforts of 500 scientists at four US research facilities and 150 chemists in Hyderabad, India in support of drug discovery in Neuroscience, Inflammation, Women’s Health\/Bone, Oncology and Cardio-vascular\/Metabolic Diseases therapeutic areas.<\/p>\n

Education<\/strong>: BS in Pharmacy and Pharmaceutical Sciences (1971), MS in Medicinal Chemistry (1974) from the School of Pharmacy, Cairo University, and Ph.D. (1979) from the University of Pennsylvania working with Professor Madeleine Joullie, followed by a two-year NIH Postdoctoral fellowship at Temple University Medical School and the department of chemistry.<\/p>\n

 <\/p>\n

\"\" \"\" \"\" \"\"<\/p>\n

 <\/p>\n